Purchase Order HHSF223201400737P

This is a $5,629,115.00 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Aptargroup Inc. for research related to environmentally friendly propellants in metered dose inhalers. The contract has a period of performance through September 20, 2027. There is no set-aside designation for this award. Aptargroup Inc. is the prime contractor, and the contract does not mention any major subcontractors. The FDA oversees the regulation of...

This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to R & D Enterprises, Inc., a for-profit small business. The contract, worth $95,980.00, is for the delivery of various scientific instruments and accessories used in bio-processing, research, and testing, such as mass spectrometers, thermal conductivity testers, rheometers, colorimeters, thermomechanical analyzers, and titration calorimeters. The contract has an...

This is a definitive cost-plus-fixed-fee contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Physical Sciences Inc., a for-profit research and development company. The contract was awarded under FDA Broad Agency Announcement BAA-18-00123, titled "Single Vial Mass Flow Rate Sensor Assessment of Freeze Drying Heterogeneity", with Proposal Number PMQWP#195. The contract has a potential value of $959,248.00 and a completion date of December...

The Food and Drug Administration (FDA) awarded a $947,868.05 firm-fixed-price purchase order to Government Scientific Source Inc., a small business, for the delivery of a high-resolution ion mobility-high resolution mass spectrometer (HRIM-HRMS) system. This system will expand the FDA's analytical capabilities for ensuring the safety and efficacy of complex drugs like biologics, peptides, and oligonucleotides. The contract has a completion date of January 31, 2024 and includes training,...

This is a $408,329.00 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Inhalation Sciences Sweden AB, a for-profit manufacturer of goods. The contract is for a study to develop an in vitro test model that resembles lung physiology to evaluate the dissolution and absorption of drugs administered via inhalation. This contract was awarded without any set-aside designations. The ultimate completion date for this contract is March...

This is a firm-fixed-price purchase order awarded by the U.S. Food and Drug Administration (FDA) to Particle Metrix Inc., a small disadvantaged business, for a Multiple Parameter Tracking Analyzer and related components. The total contract value is $85,190. The equipment will be used by the FDA's Center for Biologics Evaluation and Research (CBER) to analyze particle size distributions and concentrations of samples relevant to CBER's regulatory and research projects, such as protein particles in...

<p>This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Virgin Instruments Corp., a for-profit manufacturer, for a mass spectrometer system. The contract has a total ceiling value of $200,000.00 and was set aside for small businesses. The contract was awarded on August 19, 2013 with an ultimate completion date of September 30, 2014.</p>

<p>The Food and Drug Administration (FDA) awarded a Firm Fixed Price Purchase Order contract to Steq America, LLC for a CDER-2024-123188 DM-VACUUM PRESSURE DECAY LEAK TESTER. The contract, valued at $101,112.00, has an ultimate completion date of September 30, 2025. The contract does not have a set-aside designation. This award appears to be in support of the FDA's regulatory responsibilities over medical devices and other products under its purview.</p>

The U.S. Food and Drug Administration (FDA) awarded a firm-fixed price purchase order contract valued at $327,080 to Molecular Vista, Inc. to procure an atomic force microscope coupled with photothermal infrared imaging capabilities. This acquisition, made under the FDA's Office of Acquisition and Grants Services, responds to a request for quotations seeking a system to physically and chemically characterize nanomaterials in drug products at the nanoscale level. As a total small business...

The U.S. Food and Drug Administration (FDA) Office of Acquisition and Grants Services (OAGS) awarded a firm-fixed-price purchase order contract to Measurements Inc., a for-profit organization, for CDRH-2024-122027 Leakage Testing in Microfluidic Devices. The contract has a ceiling value of $29,486.00 and a completion date of July 4, 2025. The contract was not set aside for any specific business type. The contract originated from a solicitation posted on May 23, 2023, with a due date of June...